期刊文献+

SMARCC1基因对肝癌细胞HepG2增殖和凋亡的调控作用 被引量:2

SMARCC1 Gene Inhibits Proliferation and Apoptosis of Hepatocellular Carcinoma Cell Line HepG2
下载PDF
导出
摘要 目的探讨下调SMARCC1基因对肝癌细胞Hep G2增殖和凋亡的影响及其可能机制。方法采用siRNA法下调Hep G2细胞的SMARCC1基因,实验分为SMARCC1下调组和对照组,采用MTT法检测两组细胞24 h、48 h、72 h的增殖活性,采用流式细胞术检测两组细胞凋亡,采用RT-PCR法和Western bloting检测两组细胞caspase-3和Bcl-2基因mRNA和蛋白表达水平变化。结果 SMARCC1下调组Hep G2细胞24 h、48 h、72 h增殖活性均低于对照组,SMARCC1下调组晚期凋亡率(7. 3±0. 9%)高于对照组晚期凋亡率(1. 3±0. 1%),P <0. 01。RT-PCR实验结果表明,实验组Caspase-3的mRNA相对表达量高于对照组,实验组Bcl-2mRNA相对表达量低于对照组,均差异有统计学意义。Western blotting实验结果表明,实验组Caspase-3蛋白表达相对灰度值比高于对照组,实验组Bcl-2蛋白表达相对灰度值比低于对照组,均差异有统计学意义。结论下调SMARCC1能抑制肝癌细胞Hep G2的活性,促进其凋亡,其机制与caspase-3和Bcl-2通路有关。 Objective To investigate the effect of down-regulation of SMARCC1 gene on proliferation and apoptosis of human hepatocellular carcinoma cell line Hep G2 and its possible mechanism. Methods SMARCC1 was down-regulated by siRNA method in Hep G2 cells. The experiment was divided into SMARCC1 down-regulated group and the control group. MTT method was used to detect the proliferation activity 24 h,48 h,72 h after the transfection in the 2 groups. Flow cytometry was used to detect the apoptosis by in the 2 groups of cells. RT-PCR method and Western bloting was used to detect the mRNA and protein of Caspase-3 and Bcl-2,respectively. Results The proliferative activity of 24 h,48 h and 72 h in SMARCC1 down-regulation group was lower than that of the control group,and the late apoptosis rate in SMARCC1 down-regulation group( 7. 3 ± 0. 9%) was higher than that of the control group( 1. 3 ± 0. 1%),P < 0. 01. RT-PCR results showed that the relative expression of Caspase-3 in the experimental group was higher than that of the control group,and the relative expression of Bcl-2 mRNA in the experimental group was lower than that of the control group. The results of Western blotting showed that the relative gray value of Caspase-3 protein expression in the experimental group was higher than that of the control group,and the relative gray value ratio of Bcl-2 protein in the experimental group was lower than that of the control group,and the difference was statistically significant. Conclusion Down regulation of SMARCC1 can inhibit the activity of Hep G2 and promote apoptosis,and the mechanism is related to caspase-3 and Bcl-2 pathway.
作者 柯少波 石薇 陈佳梅 邱虎 陈永顺 KE Shaobo;SHI Wei;CHEN Jiamei(Renmin Hospital of Wuhan University,Wuhan,430060)
出处 《实用癌症杂志》 2019年第7期1053-1056,共4页 The Practical Journal of Cancer
基金 湖北省自然基金面上项目(编号:2017CFB245) 武汉大学青年教师资助项目(编号:2042016kf0127) 武汉大学人民医院引导基金项目(编号:RMYD2018M48)
关键词 肝癌 SMARCC1 细胞增殖 细胞凋亡 Liver cancer SMARCC1 Cell proliferation Cell apoptosis
  • 相关文献

参考文献10

二级参考文献119

  • 1秦叔逵,曹梦苒,钱军,华海清,王琳,何泽明.奥沙利铂为主的FOLFOX方案治疗晚期原发性肝癌[J].临床肿瘤学杂志,2005,10(1):58-60. 被引量:77
  • 2Heney NM.Natural history of superficial bladder cancer.Prog-nostic features and long-term disease course[J].Urol Clin NorthAm,1992,19(3):429.
  • 3Gui Y,Guo G,Huang Y,et al.Frequent mutations of chromatinremodeling genes in transitional cell carcinoma of the bladder[J].Nat Genet,2011,43(9):875.
  • 4Wilson BG,Roberts CW.SWI/SNF nucleosome remodellers andcancer[J].Nat Rev Cancer,2011,11(7):481.
  • 5Gao X,Tate P,Hu P,et al.ES cell pluripotency and germ-layerformation require the SWI/SNF chromatin remodeling componentBAF250a[J].Proc Natl Acad Sci USA,2010,105(18):6656.
  • 6Wiegand KC,Shah SP,Al-Agha OM,et al.ARID1A mutations inendometriosis-associated ovarian carcinomas[J].N Engl J Med,2010,363(16):1532.
  • 7Jones S,Wang TL,Shih IeM,et al.Frequent mutations of chro-matin remodeling gene ARID1Ain ovarian clear cell carcinoma[J].Science,2010,330(6001):228.
  • 8Alfons N,Antonio C.Molecular biology of laryngeal squamouscell carcinoma[J].Virchows Archiv,2003,442(1):1.
  • 9Reya T,Morrison SJ,Clarke MF,et al.Stem cells,cancer,andcancer stem cells[J].Nature,2001,414(6859):105.
  • 10Clevers H.The cancer stem cell:premises,promises and challen-ges[J].Nat Med,2011,17(3):313.

共引文献57

同被引文献18

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部